[New antimicrobial drugs: an update].
Several procedures such as antimicrobial restriction, microbial monitoring, calculated antimicrobial treatment and the development of new antimicrobials are used to reduce the resistance. The following reviews deals with new substances such as carbapenems, quinolones, ketolides, oxazolidinones, glycylcyclines, echinocandines and azoles.
Burgmann
Heinz
H
Klinische Abteilung für Infektionen und Chemotherapie, Universitätsklinik für Innere Medizin I, Währinger Gürtel 18-20, A-1090 Wien. heinz.burgmann@univie.ac.at
D000900:Anti-Bacterial Agents / Q000493:pharmacokinetics / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000493:pharmacokinetics / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy* / Q000382:microbiology; D004352:Drug Resistance, Microbial; D018432:Drug Resistance, Multiple; D015507:Drugs, Investigational / Q000493:pharmacokinetics / Q000627:therapeutic use*; D006801:Humans; D008826:Microbial Sensitivity Tests; D009181:Mycoses / Q000188:drug therapy* / Q000382:microbiology; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D000935:Antifungal Agents; D015507:Drugs, Investigational